Secondary immunodeficiencies and stem cell transplantation: issues of administration and safety of intravenous immunoglobulin.

Published

Journal Article

This article reviews the administration, efficacy, and safety of prophylactic intravenous immunoglobulin in patients with secondary immunodeficiency and those undergoing allogeneic bone marrow transplantation. Associated infections in these immunosuppressed patients are examined as they relate to transfusion-associated transmission, graft-versus-host disease, and other factors. In addition, the safety issues (including infection with cytomegalovirus and hepatitis C virus) involved in hematopoietic stem cell transplant patients given intravenous immunoglobulin are detailed by long-term follow-up of controlled clinical trials.

Full Text

Duke Authors

Cited Authors

  • Sullivan, KM

Published Date

  • 1996

Published In

Volume / Issue

  • 18 Suppl B /

Start / End Page

  • 126 - 136

PubMed ID

  • 8930450

Pubmed Central ID

  • 8930450

International Standard Serial Number (ISSN)

  • 0149-2918

Digital Object Identifier (DOI)

  • 10.1016/s0149-2918(96)80204-9

Language

  • eng

Conference Location

  • United States